Palo Alto Investors »

United Therapeutics Corporation shares owned by Palo Alto Investors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2013-03-31 $55M 897k 60.87
2012-12-31 $65M 1.2M 53.42
2012-09-30 $63M 1.1M 55.88
2012-06-30 $51M 1.0M 49.38
2012-03-31 $48M 1.0M 47.13
2011-12-31 $48M 1.0M 47.25
2011-09-30 $19M 514k 37.49
2011-06-30 $28M 503k 55.10
2011-03-31 $40M 601k 67.02
2010-12-31 $37M 589k 63.22

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Biogen Idec (BIIB)
Staar Surgical Com Par $0.01 (STAA)
ACADIA Pharmaceuticals (ACAD)
Alnylam Pharmaceuticals (ALNY)
Prothena Corp SHS (PRTA)
Iovance Biotherapeutics (IOVA)
Anaptysbio Inc Common (ANAB)
Sarepta Therapeutics (SRPT)
Alkermes SHS (ALKS)
Ptc Therapeutics I (PTCT)
Align Technology (ALGN)

View all positions for Palo Alto Investors

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation